PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.78%
Positive revenue growth while AVGO is negative. John Neff might see a notable competitive edge here.
10.01%
Gross profit growth above 1.5x AVGO's 2.66%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
15.16%
EBIT growth above 1.5x AVGO's 7.51%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
14.13%
Operating income growth above 1.5x AVGO's 7.51%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
10.15%
Net income growth 1.25-1.5x AVGO's 8.35%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
10.00%
EPS growth similar to AVGO's 9.37%. Walter Schloss would assume both have parallel share structures and profit trends.
9.63%
Similar diluted EPS growth to AVGO's 10.00%. Walter Schloss might see standard sector or cyclical influences on both firms.
0.11%
Share reduction more than 1.5x AVGO's 0.49%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.21%
Diluted share count expanding well above AVGO's 0.23%. Michael Burry would fear significant dilution to existing owners' stakes.
0.10%
Dividend growth 1.25-1.5x AVGO's 0.09%. Bruce Berkowitz would see if management’s capital return strategy is more aggressive yet sustainable.
14.65%
Similar OCF growth to AVGO's 14.65%. Walter Schloss would assume comparable operations or industry factors.
12.52%
FCF growth 75-90% of AVGO's 14.80%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
65.88%
10Y revenue/share CAGR under 50% of AVGO's 605.29%. Michael Burry would suspect a lasting competitive disadvantage.
52.11%
5Y revenue/share CAGR at 50-75% of AVGO's 78.46%. Martin Whitman would worry about a lagging mid-term growth trajectory.
20.69%
3Y revenue/share CAGR at 50-75% of AVGO's 35.36%. Martin Whitman would question if the firm lags behind competitor innovations.
320.99%
10Y OCF/share CAGR under 50% of AVGO's 749.63%. Michael Burry would worry about a persistent underperformance in cash creation.
115.68%
Below 50% of AVGO's 448.57%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
22.95%
3Y OCF/share CAGR under 50% of AVGO's 58.43%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
259.89%
Below 50% of AVGO's 560.82%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
156.30%
5Y net income/share CAGR at 50-75% of AVGO's 220.35%. Martin Whitman might see a shortfall in operational efficiency or brand power.
45.48%
Positive short-term CAGR while AVGO is negative. John Neff would see a clear advantage in near-term profit trajectory.
28.12%
Below 50% of AVGO's 699.57%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
21.70%
5Y equity/share CAGR 1.25-1.5x AVGO's 16.29%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
11.02%
Positive short-term equity growth while AVGO is negative. John Neff sees a strong advantage in near-term net worth buildup.
686.53%
Below 50% of AVGO's 4536.79%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
168.06%
Below 50% of AVGO's 627.34%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
64.54%
3Y dividend/share CAGR at 50-75% of AVGO's 108.03%. Martin Whitman might see a weaker short-term approach to distributing cash.
0.44%
Our AR growth while AVGO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-1.80%
Inventory is declining while AVGO stands at 5.46%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
4.91%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
9.59%
Positive BV/share change while AVGO is negative. John Neff sees a clear edge over a competitor losing equity.
0.02%
We have some new debt while AVGO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
1.30%
R&D growth drastically higher vs. AVGO's 2.23%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
No Data
No Data available this quarter, please select a different quarter.